53 results
F-1
EX-10.4
BLRX
Bioline Rx Ltd
24 Sep 10
Registration statement (foreign)
12:00am
for similarly situated employees and may be adjusted in the sole discretion of the Company.
2.2 Bonus Plan. Executive shall be eligible to receive one … or more bonuses determined in accordance with this Section 2.2.
2.2.1 Signing Bonus. A signing bonus of US$ 5,000, payable on the first payroll.
2.2.2
20FR12B
EX-4.4
BLRX
Bioline Rx Ltd
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
for similarly situated employees and may be adjusted in the sole discretion of the Company.
2.2 Bonus Plan. Executive shall be eligible to receive one … or more bonuses determined in accordance with this Section 2.2.
2.2.1 Signing Bonus. A signing bonus of US$ 5,000, payable on the first payroll.
2.2.2
6-K
EX-1
BLRX
Bioline Rx Ltd
28 May 19
Current report (foreign)
7:04am
, shareholder value creation and achievement of long-range goals
Special Bonus - in addition to the annual cash bonus, the Company may, from time … to time, determine that an Executive shall be paid a special bonus, considering the special contribution of such Executive to the Company, as well
6-K
EX-99
BLRX
Bioline Rx Ltd
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
restatement, the Company shall be entitled to recover from Office Holders bonus compensation granted, earned or vested based on the Company’s pre-accounting … bonus compensation granted, earned or vested based on the Company’s pre-accounting restatement financial results in the amount of the excess over what
20FR12B
EX-4.23
mp6c1j2h
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.1
3hf d6h0ju2a1p2
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.1
9ui3 8gqpdt00d
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B
EX-4.18
ohpovld hb4s
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.18
xzvjbeojng
24 Sep 10
Registration statement (foreign)
12:00am
6-K
u05i5uuog3yxqwhjxejd
4 Sep 12
Current report (foreign)
12:00am
6-K
EX-2
91dkqulg a6a4rdby0
23 Aug 11
Condensed Consolidated Interim Financial Statements
12:00am
20FR12B
bc13v5jg6fpv0eo72av4
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B/A
u03hx
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
F-1
c5puslluka7v2smcotc8
24 Sep 10
Registration statement (foreign)
12:00am
6-K
EX-10.4
gffsbucarvsnsubiv9i7
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am